In this report, the protein level of Rubicon was increased concomitant with dysregulation of autophagy in the livers of human nonalcoholic fatty liver disease (NAFLD) patients, high fat diet-fed mice, and in the culture hepatocytes treated with saturated fatty acids. Here, RUBCN is linked to metabolic dysfunction-associated steatotic liver disease.